Trials / Completed
CompletedNCT03455231
Short Course Radiotherapy in Complicated Bone Metastases Palliation
Short Course Accelerated Radiation Therapy (Sharon) in Complicated Bone Metastases Palliation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study wants to define the maximum tolerated dose (MTD), safety and efficacy of a short course radiation treatment in patients with complicated bone metastases.
Detailed description
The study wants to define the maximum tolerated dose (MTD) of a conformal short course radiation treatment delivered in twice daily fractions and 2 consecutive days, and the feasibility of this fractionation in term of safety and efficacy for symptomatic palliation of complicated bone metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Short course radiotherapy | An accelerated hypo-fractionation radiotherapy is delivered for palliation in patients with complicated bone metastases |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2018-03-06
- Last updated
- 2018-03-12
Source: ClinicalTrials.gov record NCT03455231. Inclusion in this directory is not an endorsement.